— Know what they know.
Not Investment Advice

CBUS NASDAQ

Cibus, Inc.
1W: +12.5% 1M: +9.6% 3M: +21.3% YTD: -9.0% 1Y: +27.6% 3Y: -90.7% 5Y: -99.0%
$1.71
+0.08 (+4.91%)
 
Weekly Expected Move ±8.3%
$1 $2 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 48 · $130.5M mcap · 47M float · 0.529% daily turnover · Short 65% of daily vol

Balance Sheet Trends

Total Assets
$305M -12.9% ▼
5Y CAGR: +36.9%
Total Liabilities
$283M +12.3% ▲
5Y CAGR: +60.7%
Shareholders Equity
$22M -76.3% ▼
5Y CAGR: -10.0%
Cash & Investments
$10M -31.2% ▼
5Y CAGR: -19.3%
Total Debt
$268M +638.5% ▲
5Y CAGR: +68.4%
Net Debt
$258M +1080.8% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$14M$3M$33M$14M$10M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$14M$3M$33M$14M$10M
Net Receivables$0$0$530K$1M$703K
Inventory$0$0$0$0$0
Other Current Assets$499K$705K$2M$1M$1M
Total Current Assets$15M$4M$35M$17M$12M
Property, Plant & Equip.$22M$18M$37M$45M$28M
Goodwill & Intangibles$0$158K$470M$287M$264M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$282K$0$1M$1M$926K
Total Non-Current Assets$22M$18M$509M$333M$293M
Total Assets$37M$22M$544M$350M$305M
— Liabilities —
Accounts Payable$1M$340K$6M$6M$8M
Short-Term Debt$0$0$833K$436K$3M
Deferred Revenue$0$107K$1M$932K$536K
Other Current Liabilities$3M$403K$5M$6M$5M
Total Current Liabilities$5M$2M$21M$20M$17M
Long-Term Debt$0$0$536K$226K$235M
Other Non-Current Liab.$702K$79K$167M$201M$2M
Total Non-Current Liabilities$18M$14M$185M$232M$266M
Total Liabilities$23M$15M$206M$252M$283M
— Equity —
Common Stock$4K$5K$8K$9K$79K
Retained Earnings-$196M-$212M-$480M-$731M-$858M
Accumulated OCI$0$0$8K$15K$39K
Total Stockholders Equity$14M$7M$293M$92M$22M
Total Liabilities & Equity$37M$22M$544M$350M$305M
— Key Metrics —
Total Debt$18M$14M$25M$36M$268M
Net Debt$4M$10M-$8M$22M$258M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms